Fexmid Tablet
Product Images NDC 64980-705

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Fexmid (NDC 64980-705). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rising Pharma Holdings, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (8ebfc7eb 5a9a 4f3d Af2c 370732df074f 01)

Image (8ebfc7eb 5a9a 4f3d Af2c 370732df074f 01)
Chemical structure diagram showing the molecular structure of Cyclobenzaprine Hydrochloride with corresponding chemical formula components labeled.*
FDA Label Image

Image (8ebfc7eb 5a9a 4f3d Af2c 370732df074f 02)

Image (8ebfc7eb 5a9a 4f3d Af2c 370732df074f 02)
Fexmid 7.5 mg tablets label containing Cyclobenzaprine Hydrochloride USP. The label shows a 100-tablet bottle size, with directions to see prescribing information. Manufactured by Graviti Pharmaceuticals Pvt. Ltd. in India and distributed by Rising Pharma Holdings, Inc., East Brunswick, NJ. Includes storage instructions and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.